| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 620 |
| 2 Jan 25 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
| 13 May 24 | CRL Charles River Laboratories International | Common Stock | Grant | Acquire A | No | No | 228.41 | 559 | 127.68 k | 1,467 |
| 13 May 24 | CRL Charles River Laboratories International | Stock Options Common Stock | Grant | Acquire A | No | No | 228.41 | 1,311 | 299.45 k | 1,311 |
| 2 Jan 24 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 135 | 0.00 | 454 |
| 2 Jan 24 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 888.34 | 1,607 | 1.43 mm | 1,607 |
